Interactions between CKD and MetS and the Development of CVD.

Authors

Ken-Ichi Aihara, The University of Tokushima, Graduate School of Health Biosciences, 3-18-15 Kuramoto-cho, Tokushima 770-8503, Japan
Masaki Mogi, Ehime University Graduate School of Medicine, Shitsukawa, Tohon, Ehime 791-0295, Japan
Rei Shibata, Nagoya University Graduate School of Medicine, 65 Tsurumai, Showa-Ku, Nagoya 466-8550, Japan
David Bishop-Bailey, Queen Mary University of London
Xin-Liang Ma, Thomas Jefferson UniversityFollow

Document Type

Article

Publication Date

1-1-2011

Comments

This article has been peer reviewed. It was published in: Cardiology research and practice

2011;2011:878065.

The published version is available at DOI: 10.4061/2011/878065. Copyright © Hindawi.

Abstract

Metabolic syndrome (MetS) consists of a combination of metabolic disorders, including increased abdominal circumference, hyperglycemia, elevated blood pressure, and lipid disorders. MetS is now widely accepted as a crucial risk factor for the development of cardiovascular disease (CVD) and mortality. In addition, persistent proteinuria indicating chronic kidney disease (CKD) is well known as a powerful risk factor for the progression of end-stage renal disease and CVD. In recent years, patients with CKD and MetS appear to be increasing along with increasing incidence of CVD in industrial countries.

Recommended Citation

Aihara, Ken-Ichi; Mogi, Masaki; Shibata, Rei; Bishop-Bailey, David; and Ma, Xin-Liang, "Interactions between CKD and MetS and the Development of CVD." (2011). Department of Emergency Medicine Faculty Papers. Paper 22.
https://jdc.jefferson.edu/emfp/22

PubMed ID

21629800